Cardiovascular pharmacology of serotonin and its antagonists
Van Nueten, J.M.
Revue Medicale de Liege 43(Suppl 1): 22-30
1988
ISSN/ISBN: 0370-629X PMID: 3287545 Document Number: 313120
Document emailed within 1 workday
Related Documents
Villalón, C.M.; Terrón, J.A.; Hong, E.; Saxena, P.R. 1993: The cardiovascular effects of serotonin receptor agonists and antagonists (II) Archivos del Instituto de Cardiologia de Mexico 63(6): 553-561Lucki, I.; Nobler, M.S.; Frazer, A. 1984: Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat Journal of Pharmacology and Experimental Therapeutics 228(1): 133-139
Stefano, F.J.; Dopico, A.M.; Nowogrodski, J.A.; Rothlin, R.P. 1985: Pharmacology of serotonin and vascular function Medicina 45(4): 437-441
Fuller, R.W. 1992: Basic advances in serotonin pharmacology Journal of Clinical Psychiatry 53 Suppl: 36-45
Schunack, W. 1989: Pharmacology of H2-receptor antagonists: an overview Journal of International Medical Research 17(Suppl 1): 9a
Distler, W.; Vering, A. 1992: Progesterone antagonists--pharmacology and perspectives of use Der Gynakologe 25(4): 226-230
Mills, J.G.; Wood, J.R. 1989: The pharmacology of histamine H2-receptor antagonists Methods and Findings in Experimental and Clinical Pharmacology 11(Suppl 1): 87-95
Millar, J.A.; Bramley, P.M. 1984: Clinical pharmacology of calcium antagonists Methods and Findings in Experimental and Clinical Pharmacology 6(4): 205-211
Barisano, A.; Mehl, B.; Bradbury, K. 1992: Serotonin antagonists: treatment of chemotherapy-induced emesis Mount Sinai Journal of Medicine new York 59(5): 433-437
Lance, J.W.; Anthony, M. 1970: A comparative trial of serotonin antagonists in the management of migraine Proceedings of the Australian Association of Neurologists 7: 31-35
Mignon, M.; Gislon, J.; Bonfils, S. 1978: Histamine H2 receptor antagonists. Pharmacology and clinical applications La Revue du Praticien 28(53): 4145-4146; 4151-2; 4155-4158
Beakley, B.D.; Kaye, A.M.; Kaye, A.D. 2015: Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: a Review Pain Physician 18(4): 395-400
Kohno, S. 1996: Molecular pharmacology and application to the bronchial asthma of thromboxane A2 antagonists Nihon Rinsho. Japanese Journal of Clinical Medicine 54(2): 551-558
Loo, T.L.; Johns, D.G.; Farquhar, D. 1973: Recent advances in the biochemical pharmacology of folic acid antagonists Transplantation Proceedings 5(3): 1161-1165
Engelhardt, G. 1975: On the pharmacology of 9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol (WA 335), a histamine and serotonin antagonist Arzneimittel-Forschung 25(11): 1723-1737
Lakin, K.M.; Liusov, V.A.; Ovnatanova, M.A.; Fel'dbaum, V.A.; Belousov, I.B. 1973: Change in aggregation and 5-hydroxytryptamine content of thrombocytes exposed to serotonin antagonists Kardiologiia 13(1): 27-32
Speranskaia, T.V.; Aleksandrov, P.N. 1975: The effect of serotonin and histamine antagonists on the inflammatory process in the living organism Biulleten' Eksperimental'noi Biologii i Meditsiny 79(3): 26-29
Sanders-Bush, E.; Breeding, M. 1988: Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus Journal of Pharmacology and Experimental Therapeutics 247(1): 169-173
Rogova, L.S. 1972: Simple methods of identifying peripheral M- and D-antagonists of serotonin in experiments in vivo Biulleten' Eksperimental'noi Biologii i Meditsiny 73(3): 123-124
Takano, Y.; Yaksh, T.L. 1992: Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats Journal of Pharmacology and Experimental Therapeutics 261(2): 764-772